Vancouver, Canada

Henrik Persson

This inventor holds 1 USPTO granted patent. Top assignee: Aspect Biosystems Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henrik Persson. Retrieved from https://idiyas.com/inventor/henrik-persson-ao5pjmbh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Henrik Persson and Microfluidic Bioprinting Innovation.

Introduction

Henrik Persson is an inventor associated with Vancouver, Canada, and Aspect Biosystems Ltd. His patent work addresses pump design for multi-channel microfluidic bioprinting systems.

Latest Patents

Persson is named on one patent, 1 patent: “Radial Pump Assembly and Methods of Using Same.” The disclosure describes a pump assembly with multiple pumps, such as syringe pumps, arranged radially on a mounting bracket. Each syringe pump may include a housing with a syringe retainer and a plunger driver. The radial arrangement is designed to minimize internal volume when the assembly is used in a multi-channel microfluidic bioprinting system.

Career Highlights

Persson’s disclosed invention focuses on integrating multiple pumps into a compact assembly. This design may support the space and fluid-handling requirements of microfluidic bioprinting applications.

Collaborations

Persson is associated with Aspect Biosystems Ltd. His coworker, Sebastian Steiner, is also identified in the provided information.

Conclusion

Henrik Persson’s patent describes a compact radial pump assembly intended to help meet the needs of multi-channel microfluidic bioprinting.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…